Biblio Discovery — Demo Discovery Service

2 results for "Li-Jen Cheng"

Showing 1–2 · 0.22 seconds · RSS

  1. Journal Article

    Treatment landscape, outcomes, and healthcare resource utilization in FLT3+ relapsed/refractory acute myeloid leukemia in Mexico

    Andrés Gómez De León; Jamie Jung-Hee An; Georgia Gourgioti et al.

    Cancer Treatment and Research Communications, Vol. 48 · 2026 · English · DOAJ Scopus

    Background: In Mexico, FMS-like tyrosine kinase 3 (FLT3) inhibitors have been approved for newly diagnosed or relapsed/refractory (R/R) FLT3-positive (FLT3+)acute myeloid leukemia (AML). This retrospective, physician panel-based chart review study evaluated the real-world treatment landscape…

  2. Journal Article

    Treatment Patterns and FLT3 Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study

    Cheng LJ; Gong B; Young CH et al.

    Therapeutics and Clinical Risk Management, Vol. Volume 20 · 2024 · English · DOAJ Scopus

    Li-Jen Cheng,1 Benfa Gong,2 Christopher H Young,3 Prabhuram Krishnan,1 Ying Wang,2 Hui Wei,2 Chunlin Zhou,2 Shuning Wei,2 Yan Li,2 Qiuyun Fang,2 Jia Zhong,4 Eric Q Wu,5 Yingchang Mi,2 Jianxiang Wang2 1Medical Affairs, Astellas Pharma Singapore Pte. Ltd., Singapore; 2Institute of Hematology & Blood…